Dolores Limongi
Overview
Explore the profile of Dolores Limongi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
624
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scribano D, Pasqua M, Limongi D, Nencioni L, Palamara A, Ambrosi C
Biol Res
. 2025 Jan;
58(1):9.
PMID: 39885556
No abstract available.
2.
Russo P, Milani F, Limongi D, Prezioso C, Novazzi F, Ferrante F, et al.
Mech Ageing Dev
. 2025 Jan;
224:112024.
PMID: 39818252
Introduction: Torque Teno Virus (TTV), an "orphan" virus with unclear pathology, has been associated with various diseases and immune dysfunctions. This study investigates the link between TTV viremia and clinical...
3.
Scribano D, Pasqua M, Limongi D, Nencioni L, Palamara A, Ambrosi C
Biol Res
. 2025 Jan;
58(1):2.
PMID: 39794876
Background: Acinetobacter baumannii poses a significant threat globally, causing infections primarily in healthcare settings, with high mortality rates. Its adaptability to antibiotic resistance and tolerance to various stresses, including reactive...
4.
Pellegrino M, Checconi P, Ceramella J, Prezioso C, Limongi D, Marra M, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770522
Background/objectives: Infectious diseases represent a serious threat due to rising antimicrobial resistance, particularly among multidrug-resistant bacteria and influenza viruses. Metal-based complexes, such as -heterocyclic carbene-gold (NHC-gold) complexes, show promising therapeutic...
5.
Prezioso C, Limongi D, Checconi P, Ciotti M, Legramante J, Petrangeli C, et al.
Int J Mol Sci
. 2024 Aug;
25(16).
PMID: 39201618
Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has had a significant impact on global health, with severe cases often characterized by a worsening cytokine storm. Since it has...
6.
Russo P, Milani F, De Iure A, Proietti S, Limongi D, Prezioso C, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892022
Cigarette smoking is a primary contributor to mortality risks and is associated with various diseases. Among these, COPD represents a significant contributor to global mortality and disability. The objective of...
7.
DAgostini C, Legramante J, Minieri M, Di Lecce V, Lia M, Maurici M, et al.
Diagnostics (Basel)
. 2023 Sep;
13(17).
PMID: 37685368
Background: It has been reported that mid-regional proadrenomedullin (MR-proADM) could be considered a useful tool to stratify the mortality risk in COVID-19 patients upon admission to the emergency department (ED)....
8.
Fontana C, Favaro M, Pelliccioni M, Minelli S, Bossa M, Altieri A, et al.
Diagnostics (Basel)
. 2023 Jul;
13(13).
PMID: 37443637
Background: Laboratory Automation (LA) is an innovative technology that is currently available for microbiology laboratories. LA can be a game changer by revolutionizing laboratory workflows through efficiency improvement and is...
9.
Checconi P, Coni C, Limongi D, Baldelli S, Ciccarone F, De Angelis M, et al.
FASEB J
. 2022 Dec;
37(2):e22729.
PMID: 36583688
Several redox modifications have been described during viral infection, including influenza virus infection, but little is known about glutathionylation and this respiratory virus. Glutathionylation is a reversible, post-translational modification, in...
10.
Prezioso C, Passerini S, Limongi D, Palamara A, Moens U, Pietropaolo V
Viruses
. 2022 Sep;
14(9).
PMID: 36146876
Since the non-coding control region (NCCR) and microRNA (miRNA) could represent two different and independent modalities of regulating JC polyomavirus (JCPyV) replication at the transcriptional and post-transcriptional levels, the interplay...